Windsor, CO, United States of America

Patrick Sexton

This inventor holds 2 USPTO granted patents. Top assignee: Quidel Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Sexton. Retrieved from https://idiyas.com/inventor/patrick-sexton-a09udd7l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Patrick Sexton: Innovator in Immunoassay Technology

Introduction

Patrick Sexton is a notable inventor based in Windsor, Colorado. He has made significant contributions to the field of immunoassays, particularly in the diagnosis of pre-eclampsia in pregnant women. With a total of 2 patents, his work has the potential to impact maternal health positively.

Latest Patents

Patrick's latest patents focus on methods, compositions, and kits for detecting the complement Factor B cleavage product Ba in biological samples. These innovations are designed to provide convenient, reliable, and early diagnosis or ruling out of pre-eclampsia in pregnant human subjects. His work in this area is crucial for improving health outcomes for mothers and their babies.

Career Highlights

Patrick Sexton is associated with Quidel Corporation, where he applies his expertise in immunoassay technology. His role at the company allows him to collaborate with other professionals in the field and contribute to advancements in diagnostic methods.

Collaborations

Some of Patrick's coworkers include Nikol Lee De Forest and John D Tamerius. Their collaboration enhances the innovative environment at Quidel Corporation, fostering the development of new technologies.

Conclusion

Patrick Sexton's contributions to immunoassay technology are significant, particularly in the context of maternal health. His patents reflect a commitment to improving diagnostic methods, which can lead to better health outcomes for pregnant women.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…